| | | | | |
AVTX Avalo Therapeutics, Inc. Common Stock | $13,7100 | -0,22 % | $838,42M | $814,00 | |
| $46,7300 | +0,67 % | $837,92M | $43,00 | |
| $19,9400 | +1,06 % | $836,70M | $199,00 | |
EVC Entravision Communication | $8,1500 | -5,23 % | $835,71M | $861,00 | |
ETON Eton Pharmaceutcials, Inc. Common Stock | $27,6250 | +0,05 % | $834,09M | $12,00 | |
| $25,8350 | -0,06 % | $832,22M | $273,00 | |
AMPH Amphastar Pharmaceuticals, Inc. | $18,1100 | -0,06 % | $831,15M | $116,00 | |
MATW Matthews International Corp | $25,4350 | -0,02 % | $828,11M | $12,00 | |
TBPH Theravance Biopharma, Inc. | $15,9100 | -0,06 % | $827,94M | $1,000 | |
MPB Mid Penn Bancorp, Inc. | $31,5200 | +0,03 % | $827,51M | $63,00 | |
KRO Kronos Worldwide, Inc. | $6,9300 | -1,98 % | $827,23M | $147,42K | |
ADAM Adamas Trust, Inc. Common Stock | $8,7800 | -0,11 % | $826,72M | $273,00 | |
CAPL CrossAmerica Partners LP Common units representing limited partner interests | $22,3300 | +2,01 % | $824,89M | $2,000 | |
ROOT Root, Inc. Class A Common Stock | $52,3300 | -0,08 % | $823,91M | $641,00 | |
EOI Eaton Vance Enhanced Equity Income Fund | $19,7900 | +0,00 % | $823,31M | $270,00 | |
